| Título : |
Cardio-Nephrology : Confluence of the Heart and Kidney in Clinical Practice |
| Tipo de documento: |
documento electrónico |
| Autores: |
Rangaswami, Janani, ; Lerma, Edgar V., ; Ronco, Claudio, |
| Mención de edición: |
1 ed. |
| Editorial: |
[s.l.] : Springer |
| Fecha de publicación: |
2017 |
| Número de páginas: |
XIX, 443 p. 83 ilustraciones, 57 ilustraciones en color. |
| ISBN/ISSN/DL: |
978-3-319-56042-7 |
| Nota general: |
Libro disponible en la plataforma SpringerLink. Descarga y lectura en formatos PDF, HTML y ePub. Descarga completa o por capítulos. |
| Palabras clave: |
Nefrología Cardiología Medicina de Terapia Intensiva Medicina de cuidados intensivos |
| Índice Dewey: |
616.61 |
| Resumen: |
Este libro, que abarca desde el tratamiento ambulatorio de las enfermedades cardiovasculares y renales hasta la toma de decisiones en el hospital en pacientes con enfermedades cardio-renales e interfaces complejas como la hemodiálisis en pacientes con soporte de dispositivo de asistencia ventricular, sirve como un punto de referencia único para cardiología y nefrología. médicos e investigadores que se ocupan de las importantes áreas de superposición entre estas dos especialidades. Los capítulos cubren la fisiología, los biomarcadores, los agentes terapéuticos y el espectro completo de estas comorbilidades y cuentan con secciones separadas sobre evaluaciones cardiovasculares y de ERC, estratificación de pacientes con trasplante de riñón, manejo de lípidos en ERC, estrategias de intervención e hipertensión. Los líderes en cardiología, nefrología, hipertensión y lipidología reúnen la evidencia más reciente con su experiencia clínica colectiva en este recurso invaluable. Este libro de texto es un recurso esencial para que los médicos y profesionales afines que practican la cardiología, la nefrología, los estudiantes y los médicos en formación, profundicen su comprensión de este campo crucial. . |
| Nota de contenido: |
PART I: CARDIOVASCULAR DISEASE SPECTRUM IN CHRONIC KIDNEY DISEASE -- Chapter 1 Endothelial Dysfunction and Nitric Oxide: Albuminuria as a Central Marker -- Chapter 2 Vascular and Valvular Calcification in Chronic Kidney Disease: Pathogenesis and Clinical Outcomes -- Chapter 3 Sudden Cardiac Death in CKD and ESKD: Risk Factors, Mechanisms, and Therapeutic Strategies -- Chapter 4 Coronary Artery Disease in CKD: Traditional and Nontraditional Risk Factors, Diagnosis and Management -- Chapter 5 CKD Associated Cardiomyopathy: Molecular Mechanisms, Imaging Modalities, Disease Evolution and Interventions -- PART II: CHRONIC KIDNEY DISEASE AND CAD: TWO SIDES OF THE SAME COIN -- Chapter 6 CKD as CAD Equivalent: Inflammatory Milieu and Vascular Oxidative Stress -- Chapter 7 Phosphorus and Mortality: Do we have the Panacea? -- Chapter 8 Inhibition of the Renin Angiotensin System: How far have we come? -- Chapter 9 Vitamin D and its Role in CKD and CAD: A Novel Therapeutic Target -- Chapter 10 Association ofCatalytic (Labile) Iron with Cardiovascular Morbidity and Mortality -- Chapter 11 Erythropoietin and its Cardiovascular Effects -- PART III: CARDIO-RENAL SYNDROME -- Chapter 12 Pathophysiology of the Cardio-Renal Syndromes Types 1–5: Updates from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) -- Chapter 13 Hemodynamic Cross Talk in Cardiorenal Syndrome: Era of Biomarkers -- Chapter 14 Kidney Attack: Is NGAL Set to Take the Stage with Troponins? -- Chapter 15 Ultrafiltration Therapy in Decompensated Heart Failure -- Chapter 16 Bioimpedance Vectorial Analyses in Cardio Renal Syndrome -- Chapter 17 Novel Therapies for Acute Decompensated Heart Failure -- Chapter 18 Kidney Injury in Patients with Ventricular Assist Devices -- Chapter 19 Palliation with Dual Burden of Heart and Kidney Failure: An Underutilized Strategy -- PART IV: CARDIAC EVALUATION OF THE RENAL TRANSPLANT CANDIDATE -- Chapter 20 Screening Strategies for Coronary Artery Disease (CAD) in Candidates for Kidney Transplants -- Chapter 21 Cardiac Pre-Operative Evaluation as an Opportunity to Optimize Risk Factors in Kidney Transplant Candidates -- Chapter 22 Revascularization in Patients on the Renal Transplant List: When and What is Appropriate? -- Chapter 23 Pulmonary Hypertension in the Potential Kidney Transplant Recipient -- Chapter 24 Cardiac Surveillance whilst Listed for Renal Transplantation -- Chapter 25 Post Kidney Transplant Modification of Cardiovascular Risk -- Ch. 26 Cardiomyopathy in the Potential Kidney Transplant Candidate -- PART V: ANTICOAGULATION AND ANTIPLATELET THERAPY IN CKD -- Chapter 27 Anticoagulation in Patients with Atrial Fibrillation and Chronic Kidney Disease -- Chapter 28 Anticoagulation-Related Nephropathy: Tip of the Iceberg -- Chapter 29 Impact of Antiplatelet Therapy and Platelet Reactivity Testing on Cardiovascular Outcomes in Patients with Chronic Kidney Disease -- PART VI: INTERVENTIONAL STRATEGIES IN CARDIOVASCULAR DISEASE IN CKD -- Chapter 30 Revascularization Strategies in Chronic Kidney Disease: Percutaneous Coronary Intervention vs. Coronary Artery Bypass Graft Surgery -- Chapter 31 Revascularization Strategies in CKD: Anti-Platelet Therapy, Stent Type, Timing, and Complications of PCI -- Chapter 32 Peripheral Arterial Disease in CKD: Disease Burden, Outcomes and Interventional Strategies -- Chapter 33 Contrast Induced Nephropathy -- Chapter 34 Acute Kidney Injury after Cardiac Surgery -- PART VII: THE CARDIORENOMETABOLIC SPECTRUM -- Chapter 35 Dyslipidemias in CKD and ESKD: Outcomes and Management -- Chapter 36 The Cardiac Impact of Atherosclerotic Renovascular Disease (ARVD) -- Chapter 37 Preeclampsia: A Mirror into Future Cardiovascular and Renal Health -- Chapter 38 Obstructive Sleep Apnea: A Unifying Link between Cardiovascular and Renal Disease -- PART VIII: DILEMMAS IN HYPERTENSION -- Chapter 39 Chronic Kidney Disease and BP Goals -- Chapter 40 Renal Artery Stenosis: Diagnosis and Management -- Chapter 41 Renal Denervation: Current Opinions and Practice. |
| En línea: |
https://link-springer-com.biblioproxy.umanizales.edu.co/referencework/10.1007/97 [...] |
| Link: |
https://biblioteca.umanizales.edu.co/ils/opac_css/index.php?lvl=notice_display&i |
Cardio-Nephrology : Confluence of the Heart and Kidney in Clinical Practice [documento electrónico] / Rangaswami, Janani, ; Lerma, Edgar V., ; Ronco, Claudio, . - 1 ed. . - [s.l.] : Springer, 2017 . - XIX, 443 p. 83 ilustraciones, 57 ilustraciones en color. ISBN : 978-3-319-56042-7 Libro disponible en la plataforma SpringerLink. Descarga y lectura en formatos PDF, HTML y ePub. Descarga completa o por capítulos.
| Palabras clave: |
Nefrología Cardiología Medicina de Terapia Intensiva Medicina de cuidados intensivos |
| Índice Dewey: |
616.61 |
| Resumen: |
Este libro, que abarca desde el tratamiento ambulatorio de las enfermedades cardiovasculares y renales hasta la toma de decisiones en el hospital en pacientes con enfermedades cardio-renales e interfaces complejas como la hemodiálisis en pacientes con soporte de dispositivo de asistencia ventricular, sirve como un punto de referencia único para cardiología y nefrología. médicos e investigadores que se ocupan de las importantes áreas de superposición entre estas dos especialidades. Los capítulos cubren la fisiología, los biomarcadores, los agentes terapéuticos y el espectro completo de estas comorbilidades y cuentan con secciones separadas sobre evaluaciones cardiovasculares y de ERC, estratificación de pacientes con trasplante de riñón, manejo de lípidos en ERC, estrategias de intervención e hipertensión. Los líderes en cardiología, nefrología, hipertensión y lipidología reúnen la evidencia más reciente con su experiencia clínica colectiva en este recurso invaluable. Este libro de texto es un recurso esencial para que los médicos y profesionales afines que practican la cardiología, la nefrología, los estudiantes y los médicos en formación, profundicen su comprensión de este campo crucial. . |
| Nota de contenido: |
PART I: CARDIOVASCULAR DISEASE SPECTRUM IN CHRONIC KIDNEY DISEASE -- Chapter 1 Endothelial Dysfunction and Nitric Oxide: Albuminuria as a Central Marker -- Chapter 2 Vascular and Valvular Calcification in Chronic Kidney Disease: Pathogenesis and Clinical Outcomes -- Chapter 3 Sudden Cardiac Death in CKD and ESKD: Risk Factors, Mechanisms, and Therapeutic Strategies -- Chapter 4 Coronary Artery Disease in CKD: Traditional and Nontraditional Risk Factors, Diagnosis and Management -- Chapter 5 CKD Associated Cardiomyopathy: Molecular Mechanisms, Imaging Modalities, Disease Evolution and Interventions -- PART II: CHRONIC KIDNEY DISEASE AND CAD: TWO SIDES OF THE SAME COIN -- Chapter 6 CKD as CAD Equivalent: Inflammatory Milieu and Vascular Oxidative Stress -- Chapter 7 Phosphorus and Mortality: Do we have the Panacea? -- Chapter 8 Inhibition of the Renin Angiotensin System: How far have we come? -- Chapter 9 Vitamin D and its Role in CKD and CAD: A Novel Therapeutic Target -- Chapter 10 Association ofCatalytic (Labile) Iron with Cardiovascular Morbidity and Mortality -- Chapter 11 Erythropoietin and its Cardiovascular Effects -- PART III: CARDIO-RENAL SYNDROME -- Chapter 12 Pathophysiology of the Cardio-Renal Syndromes Types 1–5: Updates from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) -- Chapter 13 Hemodynamic Cross Talk in Cardiorenal Syndrome: Era of Biomarkers -- Chapter 14 Kidney Attack: Is NGAL Set to Take the Stage with Troponins? -- Chapter 15 Ultrafiltration Therapy in Decompensated Heart Failure -- Chapter 16 Bioimpedance Vectorial Analyses in Cardio Renal Syndrome -- Chapter 17 Novel Therapies for Acute Decompensated Heart Failure -- Chapter 18 Kidney Injury in Patients with Ventricular Assist Devices -- Chapter 19 Palliation with Dual Burden of Heart and Kidney Failure: An Underutilized Strategy -- PART IV: CARDIAC EVALUATION OF THE RENAL TRANSPLANT CANDIDATE -- Chapter 20 Screening Strategies for Coronary Artery Disease (CAD) in Candidates for Kidney Transplants -- Chapter 21 Cardiac Pre-Operative Evaluation as an Opportunity to Optimize Risk Factors in Kidney Transplant Candidates -- Chapter 22 Revascularization in Patients on the Renal Transplant List: When and What is Appropriate? -- Chapter 23 Pulmonary Hypertension in the Potential Kidney Transplant Recipient -- Chapter 24 Cardiac Surveillance whilst Listed for Renal Transplantation -- Chapter 25 Post Kidney Transplant Modification of Cardiovascular Risk -- Ch. 26 Cardiomyopathy in the Potential Kidney Transplant Candidate -- PART V: ANTICOAGULATION AND ANTIPLATELET THERAPY IN CKD -- Chapter 27 Anticoagulation in Patients with Atrial Fibrillation and Chronic Kidney Disease -- Chapter 28 Anticoagulation-Related Nephropathy: Tip of the Iceberg -- Chapter 29 Impact of Antiplatelet Therapy and Platelet Reactivity Testing on Cardiovascular Outcomes in Patients with Chronic Kidney Disease -- PART VI: INTERVENTIONAL STRATEGIES IN CARDIOVASCULAR DISEASE IN CKD -- Chapter 30 Revascularization Strategies in Chronic Kidney Disease: Percutaneous Coronary Intervention vs. Coronary Artery Bypass Graft Surgery -- Chapter 31 Revascularization Strategies in CKD: Anti-Platelet Therapy, Stent Type, Timing, and Complications of PCI -- Chapter 32 Peripheral Arterial Disease in CKD: Disease Burden, Outcomes and Interventional Strategies -- Chapter 33 Contrast Induced Nephropathy -- Chapter 34 Acute Kidney Injury after Cardiac Surgery -- PART VII: THE CARDIORENOMETABOLIC SPECTRUM -- Chapter 35 Dyslipidemias in CKD and ESKD: Outcomes and Management -- Chapter 36 The Cardiac Impact of Atherosclerotic Renovascular Disease (ARVD) -- Chapter 37 Preeclampsia: A Mirror into Future Cardiovascular and Renal Health -- Chapter 38 Obstructive Sleep Apnea: A Unifying Link between Cardiovascular and Renal Disease -- PART VIII: DILEMMAS IN HYPERTENSION -- Chapter 39 Chronic Kidney Disease and BP Goals -- Chapter 40 Renal Artery Stenosis: Diagnosis and Management -- Chapter 41 Renal Denervation: Current Opinions and Practice. |
| En línea: |
https://link-springer-com.biblioproxy.umanizales.edu.co/referencework/10.1007/97 [...] |
| Link: |
https://biblioteca.umanizales.edu.co/ils/opac_css/index.php?lvl=notice_display&i |
|  |